Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 23201982)

1.

The detection of patients at risk of gastrointestinal toxicity during pelvic radiotherapy by electronic nose and FAIMS: a pilot study.

Covington JA, Wedlake L, Andreyev J, Ouaret N, Thomas MG, Nwokolo CU, Bardhan KD, Arasaradnam RP.

Sensors (Basel). 2012 Sep 26;12(10):13002-18. doi: 10.3390/s121013002.

2.

Evaluation of gut bacterial populations using an electronic e-nose and field asymmetric ion mobility spectrometry: further insights into 'fermentonomics'.

Arasaradnam RP, Ouaret N, Thomas MG, Gold P, Quraishi MN, Nwokolo CU, Bardhan KD, Covington JA.

J Med Eng Technol. 2012 Oct;36(7):333-7. doi: 10.3109/03091902.2012.690015. Epub 2012 Jul 5.

PMID:
22764881
3.

Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists.

Henson CC, Andreyev HJ, Symonds RP, Peel D, Swindell R, Davidson SE.

Clin Oncol (R Coll Radiol). 2011 Oct;23(8):552-7. doi: 10.1016/j.clon.2011.04.002. Epub 2011 May 6.

PMID:
21550216
4.

Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy.

Wedlake LJ, Shaw C, Whelan K, Andreyev HJ.

Aliment Pharmacol Ther. 2013 Jun;37(11):1046-56. doi: 10.1111/apt.12316. Epub 2013 Apr 23. Review.

PMID:
23611411
5.

Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study.

Wedlake L, Thomas K, McGough C, Andreyev HJ.

Eur J Cancer. 2008 Oct;44(15):2212-7. doi: 10.1016/j.ejca.2008.07.018. Epub 2008 Aug 27.

PMID:
18760593
6.

A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease.

Arasaradnam RP, Ouaret N, Thomas MG, Quraishi N, Heatherington E, Nwokolo CU, Bardhan KD, Covington JA.

Inflamm Bowel Dis. 2013 Apr;19(5):999-1003. doi: 10.1097/MIB.0b013e3182802b26.

PMID:
23478806
7.

"Pelvic radiation disease": new understanding and new solutions for a new disease in the era of cancer survivorship.

Andreyev HJ, Wotherspoon A, Denham JW, Hauer-Jensen M.

Scand J Gastroenterol. 2011 Apr;46(4):389-97. doi: 10.3109/00365521.2010.545832. Epub 2010 Dec 29. Review.

PMID:
21189094
8.

Faecal incontinence: A late side-effect of pelvic radiotherapy.

Putta S, Andreyev HJ.

Clin Oncol (R Coll Radiol). 2005 Sep;17(6):469-77.

PMID:
16149292
9.

Gastrointestinal complications of pelvic radiotherapy: medical and surgical management strategies.

Hogan NM, Kerin MJ, Joyce MR.

Curr Probl Surg. 2013 Sep;50(9):395-407. doi: 10.1067/j.cpsurg.2013.04.004. Review. No abstract available.

PMID:
23930906
10.

Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial.

Arcangeli S, Strigari L, Soete G, De Meerleer G, Gomellini S, Fonteyne V, Storme G, Arcangeli G.

Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):39-45. doi: 10.1016/j.ijrobp.2008.04.005. Epub 2008 Jun 4.

PMID:
18538488
11.
12.

How patients manage gastrointestinal symptoms after pelvic radiotherapy.

Gami B, Harrington K, Blake P, Dearnaley D, Tait D, Davies J, Norman AR, Andreyev HJ.

Aliment Pharmacol Ther. 2003 Nov 15;18(10):987-94.

13.

Late effect of multiple daily fraction palliation schedule for advanced pelvic malignancies (RTOG 8502).

Spanos WJ Jr, Clery M, Perez CA, Grigsby PW, Doggett RL, Poulter CA, Steinfeld AD.

Int J Radiat Oncol Biol Phys. 1994 Jul 30;29(5):961-7.

PMID:
8083097
14.

Measurement tools for gastrointestinal symptoms in radiation oncology.

West CM, Davidson SE.

Curr Opin Support Palliat Care. 2009 Mar;3(1):36-40. doi: 10.1097/SPC.0b013e328325d18d. Review.

PMID:
19262387
16.

Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial.

Andreyev HJ, Benton BE, Lalji A, Norton C, Mohammed K, Gage H, Pennert K, Lindsay JO.

Lancet. 2013 Dec 21;382(9910):2084-92. doi: 10.1016/S0140-6736(13)61648-7. Epub 2013 Sep 23.

PMID:
24067488
17.

Defining pelvic-radiation disease for the survivorship era.

Andreyev HJ, Wotherspoon A, Denham JW, Hauer-Jensen M.

Lancet Oncol. 2010 Apr;11(4):310-2. doi: 10.1016/S1470-2045(10)70026-7. Epub 2010 Feb 8. No abstract available.

PMID:
20149738
18.

Late gastrointestinal complications after pelvic radiotherapy: radiation enteritis.

Ruiz-Tovar J, Morales V, Hervás A, Sanjuanbenito A, Lobo E, Martínez-Molina E.

Clin Transl Oncol. 2009 Aug;11(8):539-43.

PMID:
19661029
19.

Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA.

Martenson JA, Halyard MY, Sloan JA, Proulx GM, Miller RC, Deming RL, Dick SJ, Johnson HA, Tai TH, Zhu AW, Keit J, Stien KJ, Atherton PJ.

J Clin Oncol. 2008 Nov 10;26(32):5248-53. doi: 10.1200/JCO.2008.17.1546. Epub 2008 Sep 2.

20.

Effect of pelvic irradiation on gastrointestinal function: a prospective longitudinal study.

Yeoh E, Horowitz M, Russo A, Muecke T, Robb T, Maddox A, Chatterton B.

Am J Med. 1993 Oct;95(4):397-406.

PMID:
8213872
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk